Jacobs Levy Equity Management Portfolio holdings
Jacobs Levy Equity Management manages U.S. stock portfolios, and its owners Bruce Jacobs and Ken Levy pioneered a research method called disentangling. The firm was founded in 1986, and Jacobs and Levy spent more than three years studying market inefficiencies in U.S. stocks before taking on client money in 1990. Disentangling examines many factors that move stock prices at once, to isolate the separate effect of each, and the firm blends it with behavioral finance theory and human judgment. It runs long-only and long/short portfolios across large and small companies, including versions that hold about 130% or 150% of capital in long positions and 30% or 50% in short ones. Its clients are institutions such as pension plans, endowments, foundations and sovereign wealth funds.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
KLA
KLAC
|
+$325M |
| 2 |
CrowdStrike
CRWD
|
+$225M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$186M |
| 4 |
Sandisk
SNDK
|
+$155M |
| 5 |
Sysco
SYY
|
+$147M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$418M |
| 2 |
ServiceNow
NOW
|
+$262M |
| 3 |
Apple
AAPL
|
+$260M |
| 4 |
Masco
MAS
|
+$163M |
| 5 |
Roku
ROKU
|
+$139M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.14% |
| 2 | Financials | 13.01% |
| 3 | Consumer Discretionary | 12.82% |
| 4 | Industrials | 11.2% |
| 5 | Healthcare | 10.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
551
Community Healthcare Trust
CHCT
$423M
| $2.46M | 0.01% |
134,355
-13,856
| -9% | -$241K |
2025 Q2
4 quarters
|
|
552
Finance of America Companies
FOA
$100M
| $2.45M | 0.01% |
89,168
+18,489
| +26% | +$377K |
2025 Q4
2 quarters
|
|
553
First Horizon
FHN
$11.1B
| $2.45M | 0.01% |
95,705
| – | – |
2026 Q1
1 quarter
|
|
554
GoDaddy
GDDY
$13.8B
| $2.45M | 0.01% |
+28,881
| New | +$2.44M |
2026 Q2
0 quarters
|
|
555
Rimini Street
RMNI
$513M
| $2.44M | 0.01% |
572,176
+130,847
| +30% | +$496K |
2025 Q1
5 quarters
|
|
556
Louisiana-Pacific
LPX
$5.3B
| $2.43M | 0.01% |
30,829
-3,045
| -9% | -$225K |
2019 Q4
26 quarters
|
|
557
Balchem Corp
BCPC
$5.52B
| $2.39M | 0.01% |
14,129
-843
| -6% | -$140K |
2025 Q1
5 quarters
|
|
558
Central Pacific Financial
CPF
$988M
| $2.37M | 0.01% |
62,112
-6,434
| -9% | -$224K |
2015 Q3
43 quarters
|
|
559
eGain
EGAN
$157M
| $2.37M | 0.01% |
375,896
+60,429
| +19% | +$443K |
2025 Q4
2 quarters
|
|
560
Exzeo Group
XZO
$1.43B
| $2.36M | 0.01% |
+139,911
| New | +$2.06M |
2026 Q2
0 quarters
|
|
561
Tenet Healthcare
THC
$22.8B
| $2.35M | 0.01% |
12,575
+4,856
| +63% | +$893K |
2025 Q3
3 quarters
|
|
562
Hope Bancorp
HOPE
$1.66B
| $2.34M | 0.01% |
171,411
+120,776
| +239% | +$1.51M |
2025 Q1
5 quarters
|
|
563
First Industrial Realty Trust
FR
$7.32B
| $2.34M | 0.01% |
38,111
-193,056
| -84% | -$12M |
2024 Q2
8 quarters
|
|
564
Stoneridge
SRI
$145M
| $2.33M | 0.01% |
318,518
+54,839
| +21% | +$376K |
2023 Q2
12 quarters
|
|
565
Old Republic International
ORI
$9.5B
| $2.32M | 0.01% |
56,597
-260,426
| -82% | -$10.3M |
2024 Q2
8 quarters
|
|
566
Live Oak Bancshares
LOB
$1.63B
| $2.29M | 0.01% |
56,079
-76,739
| -58% | -$2.87M |
2024 Q1
9 quarters
|
|
567
Septerna Inc
SEPN
$2.03B
| $2.28M | 0.01% |
68,180
+39,744
| +140% | +$1.13M |
2025 Q3
3 quarters
|
|
568
Telos
TLS
$540M
| $2.28M | 0.01% |
496,220
+142,004
| +40% | +$628K |
2022 Q3
15 quarters
|
|
569
Designer Brands
DBI
$326M
| $2.28M | 0.01% |
390,259
-4,384
| -1% | -$30.8K |
2025 Q2
4 quarters
|
|
570
Paysign
PAYS
$541M
| $2.27M | 0.01% |
276,928
-72,062
| -21% | -$477K |
2025 Q3
3 quarters
|
|
571
Arcutis Biotherapeutics
ARQT
$3.57B
| $2.26M | 0.01% |
+86,027
| New | +$2M |
2026 Q2
0 quarters
|
|
572
Miller Industries
MLR
$546M
| $2.25M | 0.01% |
44,064
-12,140
| -22% | -$584K |
2024 Q3
7 quarters
|
|
573
TETRA Technologies
TTI
$948M
| $2.23M | 0.01% |
+197,180
| New | +$1.93M |
2026 Q2
0 quarters
|
|
574
Entrada Therapeutics
TRDA
$199M
| $2.23M | 0.01% |
303,459
-30,455
| -9% | -$292K |
2024 Q2
8 quarters
|
|
575
Omada Health Inc
OMDA
$889M
| $2.23M | 0.01% |
101,373
-293,865
| -74% | -$4.69M |
2025 Q4
2 quarters
|
|
Similar funds
Jacobs Levy Equity Management's Q2 2026 Portfolio in Review
As of Q2 2026, Jacobs Levy Equity Management held 1,111 positions worth $27.8B, up 17% from $23.8B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Jacobs Levy Equity Management's Q2 2026 filing shows 158 new, 319 increased, 438 reduced and 177 closed positions. Its largest new stake was Sysco: 1,938,184 shares worth $162M. The largest sale was Qualcomm, an estimated $418M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 31% a quarter earlier, followed by Financials and Consumer Discretionary.
- Jacobs Levy Equity Management's largest Q2 2026 buy was Sysco: 1,938,184 shares worth $162M.
- Jacobs Levy Equity Management added most to KLA in Q2 2026, an estimated $325M increase.
- Jacobs Levy Equity Management's biggest Q2 2026 reduction was Qualcomm, cutting an estimated $418M.
- Jacobs Levy Equity Management fully exited Roku in Q2 2026, selling an estimated $139M.
- Jacobs Levy Equity Management's ten largest holdings make up 28% of its $27.8B portfolio in Q2 2026.
- Jacobs Levy Equity Management opened 158 new positions and closed 177 in Q2 2026.
- Jacobs Levy Equity Management's portfolio value rose 17% quarter-over-quarter to $27.8B.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2026, filed 14 Aug 2026.